UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P16 Under one roof: a practical approach to record disease progression

Rheumatology (Oxford, England), 2018-10, Vol.57 (suppl_8)

2018

Volltextzugriff (PDF)

Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis

Arthritis & rheumatology (Hoboken, N.J.), 2022-01, Vol.74 (1), p.124-133

2022

Volltextzugriff (PDF)

The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial

EClinicalMedicine, 2019-07, Vol.12, p.79-87

2019

Volltextzugriff (PDF)

Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management

Pediatric rheumatology online journal, 2018-12, Vol.16 (1), p.80-80, Article 80

2018

Volltextzugriff (PDF)

Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis

Cochrane database of systematic reviews, 2016-01, Vol.2021 (1), p.CD006838

2016

Volltextzugriff (PDF)

E050 Angiotensin converting enzyme for the diagnosis of childhood sarcoidosis

Rheumatology (Oxford, England), 2024-04, Vol.63 (Supplement_1)

2024

Volltextzugriff (PDF)

British Isles Survey of Methotrexate Monitoring Practice During Treatment of Juvenile Idiopathic Arthritis

Seminars in arthritis and rheumatism, 2011-02, Vol.40 (4), p.358-364.e2

2011

Volltextzugriff (PDF)

Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis

Cochrane database of systematic reviews, 2012-09, Vol.2017 (9), p.CD007336

2012

Volltextzugriff (PDF)

P48 The puppet prescriber or custodian of the NHS purse: are patients really at the centre of what we do?

Rheumatology (Oxford, England), 2019-10, Vol.58 (Supplement_4)

2019

Volltextzugriff (PDF)

P18 Audit on pre-methotrexate screening in a paediatric rheumatology centre

Rheumatology (Oxford, England), 2019-10, Vol.58 (Supplement_4)

2019

Volltextzugriff (PDF)

P19 Mycophenolate mofetil in paediatric uveitis: an early experience

Rheumatology (Oxford, England), 2019-10, Vol.58 (Supplement_4)

2019

Volltextzugriff (PDF)

Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis

Cochrane database of systematic reviews, 2012-03 (3), p.CD006838

2012

Volltextzugriff (PDF)

Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus

Rheumatology (Oxford, England), 2022-08, Vol.61 (8), p.3378-3389

2022

Volltextzugriff (PDF)

Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort

Arthritis & rheumatology (Hoboken, N.J.), 2012-07, Vol.64 (7), p.2356-2365

2012

Volltextzugriff (PDF)

O23 Pulmonary emboli in a teenager with GPA: management dilemmas

Rheumatology advances in practice, 2020-11, Vol.4 (Supplement_1)

2020

Volltextzugriff (PDF)

P11 An unusual case of Systemic Sclerosis/JDM overlap in a child with PAX8-related congenital hypothyroidism

Rheumatology advances in practice, 2022-09, Vol.6 (Supplement_1)

2022

Volltextzugriff (PDF)

Contributors to Organ Damage in Childhood Lupus: Corticosteroid Use and Disease Activity

Rheumatology (Oxford, England), 2024-10

2024

Volltextzugriff (PDF)

‘It is good to have a target in mind’: qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus

Rheumatology (Oxford, England), 2021-12, Vol.60 (12), p.5630-5641

2021

Volltextzugriff (PDF)

Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study

Arthritis research & therapy, 2014-07, Vol.16 (4), p.R138-R138, Article R138

2014

Volltextzugriff (PDF)

Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE

Rheumatology (Oxford, England), 2023-02, Vol.62 (SI2), p.SI210-SI225

2023

Volltextzugriff (PDF)

P47 Profile of patients attending the combined paediatric rheumatology/immunology clinic

Rheumatology (Oxford, England), 2018-10, Vol.57 (suppl_8)

2018

Volltextzugriff (PDF)

Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study

Rheumatology (Oxford, England), 2021-11, Vol.60 (11), p.5271-5281

2021

Volltextzugriff (PDF)

Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis

Arthritis & rheumatology (Hoboken, N.J.), 2016-11, Vol.68 (11), p.2806-2816

2016

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

P16 Under one roof: a practical approach to record disease progression

Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis

Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK

The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial

Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management

Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis

E050 Angiotensin converting enzyme for the diagnosis of childhood sarcoidosis

British Isles Survey of Methotrexate Monitoring Practice During Treatment of Juvenile Idiopathic Arthritis

Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis

P48 The puppet prescriber or custodian of the NHS purse: are patients really at the centre of what we do?

P18 Audit on pre-methotrexate screening in a paediatric rheumatology centre

P19 Mycophenolate mofetil in paediatric uveitis: an early experience

Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis

Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus

Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort

O23 Pulmonary emboli in a teenager with GPA: management dilemmas

P11 An unusual case of Systemic Sclerosis/JDM overlap in a child with PAX8-related congenital hypothyroidism

Contributors to Organ Damage in Childhood Lupus: Corticosteroid Use and Disease Activity

‘It is good to have a target in mind’: qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus

Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study

Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE

P47 Profile of patients attending the combined paediatric rheumatology/immunology clinic

Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study

Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study

Suchergebnisse filtern